COLUCID PHARMACEUTICALS INC's ticker is CLCD and the CUSIP is 19716T101. A total of 20 filers reported holding COLUCID PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,184,000 | -18.2% | 60,000 | -14.3% | 0.03% | -30.0% |
| Q3 2016 | $2,671,000 | +553.1% | 70,000 | +40.0% | 0.04% | +566.7% |
| Q2 2016 | $409,000 | +31.9% | 50,000 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $310,000 | -26.0% | 50,000 | 0.0% | 0.01% | -37.5% |
| Q4 2015 | $419,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,156,563 | $120,423,000 | 10.70% |
| BVF INC/IL | 763,300 | $29,120,000 | 5.49% |
| GREAT POINT PARTNERS LLC | 400,000 | $15,260,000 | 3.89% |
| VHCP Management II, LLC | 159,110 | $6,070,000 | 3.12% |
| Vivo Capital, LLC | 225,000 | $8,584,000 | 2.68% |
| VHCP Management, LLC | 68,190 | $2,601,000 | 2.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $15,260,000 | 2.48% |
| NEXTHERA CAPITAL LP | 100,000 | $3,815,000 | 2.34% |
| AWM Investment Company, Inc. | 288,919 | $11,022,000 | 2.02% |
| Perceptive Advisors | 552,030 | $21,060,000 | 1.36% |